[go: up one dir, main page]

NO20020555D0 - Mikropartikler for lungeadministrering - Google Patents

Mikropartikler for lungeadministrering

Info

Publication number
NO20020555D0
NO20020555D0 NO20020555A NO20020555A NO20020555D0 NO 20020555 D0 NO20020555 D0 NO 20020555D0 NO 20020555 A NO20020555 A NO 20020555A NO 20020555 A NO20020555 A NO 20020555A NO 20020555 D0 NO20020555 D0 NO 20020555D0
Authority
NO
Norway
Prior art keywords
microparticles
lung administration
lung
administration
Prior art date
Application number
NO20020555A
Other languages
English (en)
Other versions
NO20020555L (no
Inventor
Joel Richard
Claire Dulieu
Dominique Le Meurlay
Jean-Pierre Benoit
Original Assignee
Mainelab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mainelab filed Critical Mainelab
Publication of NO20020555D0 publication Critical patent/NO20020555D0/no
Publication of NO20020555L publication Critical patent/NO20020555L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/22—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of calcitonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
NO20020555A 1999-08-11 2002-02-04 Mikropartikler for lungeadministrering NO20020555L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9910411A FR2797398B1 (fr) 1999-08-11 1999-08-11 Microparticules pour administration pulmonaire
PCT/FR2000/002282 WO2001012160A1 (fr) 1999-08-11 2000-08-09 Microparticules pour administration pulmonaire

Publications (2)

Publication Number Publication Date
NO20020555D0 true NO20020555D0 (no) 2002-02-04
NO20020555L NO20020555L (no) 2002-04-09

Family

ID=9549086

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020555A NO20020555L (no) 1999-08-11 2002-02-04 Mikropartikler for lungeadministrering

Country Status (13)

Country Link
EP (1) EP1204409A1 (no)
JP (1) JP2003506479A (no)
KR (1) KR20020038719A (no)
CN (1) CN1220484C (no)
AU (1) AU784168B2 (no)
CA (1) CA2380883A1 (no)
FR (1) FR2797398B1 (no)
HU (1) HUP0202545A3 (no)
IL (1) IL148063A0 (no)
MX (1) MXPA02001520A (no)
NO (1) NO20020555L (no)
WO (1) WO2001012160A1 (no)
ZA (1) ZA200201109B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2809309B1 (fr) * 2000-05-23 2004-06-11 Mainelab Microspheres a liberation prolongee pour administration injectable
WO2003077891A1 (fr) * 2002-03-18 2003-09-25 Yamanouchi Pharmaceutical Co., Ltd. Compositions medicales en poudre pour inhalation et procede de production de celles-ci
JP2005279334A (ja) * 2004-03-26 2005-10-13 Kao Corp 複合化粒子の製造方法
WO2007009164A1 (en) 2005-07-15 2007-01-25 Eiffel Technologies Limited Method of particle formation
EP1757361A1 (en) * 2005-08-23 2007-02-28 Feyecon Development & Implementation B.V. Process for the preparation of encapsulates through precipitation
PL2061427T3 (pl) * 2006-09-15 2011-12-30 Echo Pharmaceuticals Bv Granulat zawierający substancję farmaceutycznie aktywną i emulgator oraz sposób jego wytwarzania
CN101143131B (zh) * 2006-09-15 2012-03-07 国家纳米技术与工程研究院 一种利用超临界流体技术制备人胰岛素吸入干粉的方法
US7947227B2 (en) * 2007-03-23 2011-05-24 Geno Llc Kit for the conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
KR101102834B1 (ko) * 2010-02-24 2012-01-05 충남대학교산학협력단 신규한 리포좀 제조 방법 및 장치
JP5672554B2 (ja) * 2010-08-19 2015-02-18 Ｊｃｒファーマ株式会社 皮下又は経皮吸収用組成物
CN102872027B (zh) * 2012-09-18 2014-03-12 刘晓忠 一种治疗肺部疾病的药物颗粒的制备和吸入式复方气雾剂的制备

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04222662A (ja) * 1990-12-25 1992-08-12 Nippon Steel Chem Co Ltd 固体表面へのポリマー皮膜形成方法
EP0706821A1 (en) * 1994-10-06 1996-04-17 Centre De Microencapsulation Method of coating particles
AU695207B2 (en) * 1995-03-28 1998-08-06 Fidia Farmaceutici S.P.A. Nanospheres comprising a biocompatible polysaccharide
FR2753639B1 (fr) * 1996-09-25 1998-12-11 Procede de preparation de microcapsules de matieres actives enrobees par un polymere et nouvelles microcapsules notamment obtenues selon le procede
US5766637A (en) * 1996-10-08 1998-06-16 University Of Delaware Microencapsulation process using supercritical fluids
CA2277801C (en) * 1997-01-16 2002-10-15 Massachusetts Institute Of Technology Preparation of particles for inhalation
JPH1147681A (ja) * 1997-08-05 1999-02-23 Kira Keshohin Kk 超臨界流体を用いた微粒子のコーティング方法及び塗装物
JPH11197494A (ja) * 1998-01-13 1999-07-27 Kenji Mishima 超臨界流体を用いた微小粒子コーティング

Also Published As

Publication number Publication date
HUP0202545A3 (en) 2004-05-28
EP1204409A1 (fr) 2002-05-15
HUP0202545A2 (hu) 2004-03-01
WO2001012160A1 (fr) 2001-02-22
NO20020555L (no) 2002-04-09
AU7010400A (en) 2001-03-13
IL148063A0 (en) 2002-09-12
AU784168B2 (en) 2006-02-16
CN1220484C (zh) 2005-09-28
CN1461211A (zh) 2003-12-10
CA2380883A1 (fr) 2001-02-22
MXPA02001520A (es) 2003-07-21
FR2797398B1 (fr) 2002-10-18
FR2797398A1 (fr) 2001-02-16
JP2003506479A (ja) 2003-02-18
KR20020038719A (ko) 2002-05-23
ZA200201109B (en) 2002-10-30

Similar Documents

Publication Publication Date Title
NO20022922D0 (no) Inhalasjonsanordning
ATE392890T1 (de) Hydrogel-gesteuerte dosierungsform
DK1637127T3 (da) Terapeutisk mikroskum
NO20015175L (no) Farmasöytisk sammensetning
FI991485L (fi) Uusi farmaseuttinen koostumus
NO20021400D0 (no) Terapeutiske konazolinderivater
NO994094D0 (no) Stigerörsanordning
DK1128831T3 (da) Farmaceutisk moxifloxacinpræparat
DE60126089D1 (de) Verabreichungssystem
NO20022921D0 (no) Inhalasjonsanordning
EE200200150A (et) Preparaat
NO20015149L (no) Nytt farmasöytisk preparat
NO20022606D0 (no) Farmasöytiske kombinasjoner
NO20014926L (no) Farmasöytiske forbindelser
NO20015148L (no) Nytt farmasöytisk preparat
NO20020555L (no) Mikropartikler for lungeadministrering
FI20002217L (fi) Inhalaatiopartikkelit
FI4488U1 (fi) Farmaseuttinen koostumus
NO20015104L (no) Nytt farmasöytisk preparat
IS6163A (is) Lyfjakomplex
NO20015105L (no) Nytt farmasöytisk preparat
NO20021036D0 (no) Farmasöytisk preparat
DE50003442D1 (de) Kleiderbügel
DE60026702D1 (de) Beatmungssystem
UA3612S (uk) Респіратор протиаерозольний

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application